Moolec Science
Financials
Estimates*
USD | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Revenues | - | - | <1m | 3.8m | 6.2m |
% growth | - | - | - | 324 % | 60 % |
EBITDA | (2.0m) | (3.7m) | (52.1m) | - | - |
% EBITDA margin | - | - | (5754 %) | - | - |
Profit | (2.0m) | (4.5m) | (51.8m) | - | - |
% profit margin | - | - | (5722 %) | - | - |
R&D budget | <1m | <1m | 1.4m | - | - |
R&D % of revenue | - | - | 149 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $138m Valuation: $504m -253.7x EV/LTM EBITDA | SPAC IPO | |
* | $50.0m | Post IPO Equity | |
* | $30.0m | Post IPO Convertible | |
Total Funding | - |
Related Content
Recent News about Moolec Science
EditMoolec Science is a science-based ingredient company that uses a disruptive technology called Molecular Farming to produce real animal proteins in plants. This technology is cost-effective and environmentally friendly, using fewer resources than other alternatives. Moolec's approach is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.
Moolec's innovation and traceability starts at the beginning of the food ingredients value chain. They use genetic engineering of plants to include animal genetic information in order to enable them to produce proteins the way animals do. This process is strictly evaluated for potential risks to humans, livestock, and the environment.
Moolec Science is pioneering in achieving approvals and industrial scale for a Molecular Farm. This makes them different from other businesses in the same industry, as they are able to offer a more sustainable, traceable, and cost-effective alternative protein product. They are working to create safe solutions for human consumption, and are committed to building a more equitable and sustainable food system.